IL10 and COVID-19: In addition, TGFβ1, TGFβ3, IL-6, and IL-10 may be influential biomarkers of COVID-19 severity during the early phase of infection, whereas Th2 cytokines, IL-4 and IL-13, may be markers of persisting severity.